A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA adverse event reporting system

Background: Everolimus is an inhibitor of the mammalian target of rapamycin and is used to treat various tumors. The presented study aimed to evaluate the Everolimus-associated adverse events (AEs) through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS).Meth...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bin Zhao, Yumei Fu, Shichao Cui, Xiangning Chen, Shu Liu, Lan Luo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-03-01
Colecção:	Frontiers in Pharmacology
Assuntos:	Everolimus data mining FAERS pharmacovigilance adverse event
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1333662/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!